• Skip to main content
  • Skip to after header navigation
  • Skip to site footer
ERN: Emerging Researchers National Conference in STEM

ERN: Emerging Researchers National Conference in STEM

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Conference
  • Abstracts
    • Undergraduate Abstract Locator
    • Graduate Abstract Locator
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
  • Travel Awards
  • Resources
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • Login

Mechanisms of Chemoresistance in Ovarian Cancer Cell Lines

Undergraduate #24
Discipline: Biological Sciences
Subcategory: Cancer Research

Briana Spruill-Harrell - Norfolk State University


Ovarian cancer is the fifth leading cause of death in women. Due to the lack of symptoms and early screening tests, ovarian cancer is diagnosed at more advanced stages resulting in high mortality rates. Most ovarian cancer are non-responsive to cisdiammine-dichloro-platinum, or cisplatin, one of the most potent antitumor agents in chemotherapy. This drug targets DNA replication during cellular repair of damaged DNA as well as activates apoptosis. Cisplatin has an initial response rate of 70%, however treatment only results in a 5-year patient survival rate of 15-20%. In this study, we evaluate biological responses of cisplatin-resistant and parental cells. Ovarian cancer cell line, Caov-3 response to cisplatin is assessed by dose-curve experiments. Resistant cells are generated by exposure to sub-lethal dose of cisplatin. Biological responses of parental and cisplatin-resistant cells are evaluated in the absence or presence of lysophosphatic acid (LPA), a bioactive phospholipid that is highly expressed in ovarian cancer patients. Our long-term goal is to identify novel cellular targets that may drive chemoresistance in ovarian cancer subtypes.

Funder Acknowledgement(s): WBHR-LSAMP Grant (Howard and NSU) P2040007

Faculty Advisor: Regina Oyesanya, raoyesanya@nsu.edu

Role: I had hands on with the whole research project. I cultured cells, did the MTT assay and assisted my advisor with the wound closure assay.

Sidebar

Abstract Locators

  • Undergraduate Abstract Locator
  • Graduate Abstract Locator

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW
Washington,DC 20005
202-326-6400
Contact Us
About Us

  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube

The World’s Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

Focus Areas

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law

© 2023 American Association for the Advancement of Science